Lupin gets US FDA nod for generic medicine to treat heart ailments

Lupin gets US FDA nod for generic medicine to treat heart ailments

These are the generic equivalent of Effient tablets, 5 mg and 10 mg of Cosette Pharmaceuticals, Inc

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:28 PM IST
article-image
Lupin gets US FDA nod for generic medicine to treat heart ailments | Image credit: Wikipedia (Representative)

Lupin Ltd announced via an exchange filing that it has received approval from the USFDA for its generic version of Prasugrel tablets.

The medication is recommended for use in patients who have recently experienced heart attacks, strokes, or blood clots in stents in order to prevent other severe heart and blood vessel issues.

The company said in the regulatory filing that the US Food and Drug Administration (US FDA) had approved the Abbreviated New Drug Application (ANDA) for Prasugrel tablets in strengths of 5 mg and 10 mg.

These are the generic equivalent of Effient tablets, 5 mg and 10 mg of Cosette Pharmaceuticals, Inc.

"The product will be manufactured at Lupin's facility in Goa, India," it added.

Prasugrel Tablets 5 mg and 10 mg had estimated annual sales of USD 18 million in the US, Lupin said citing IQVIA MAT September 2022 data.

RECENT STORIES

5G Future: Ericsson Mulls Telecom Equipment Export From India In Future

5G Future: Ericsson Mulls Telecom Equipment Export From India In Future

SEBI Slaps ₹11.9 Crore Fine On 19 Entities For 'Pump And Dump' Of Superior Finlease Shares

SEBI Slaps ₹11.9 Crore Fine On 19 Entities For 'Pump And Dump' Of Superior Finlease Shares

Mercury EV-Tech Limited Strengthens Market Position with Strategic Acquisitions

Mercury EV-Tech Limited Strengthens Market Position with Strategic Acquisitions

Visionary Advocate Andrew Spira Highlights Universal Basic Income's Success In Alleviating Poverty...

Visionary Advocate Andrew Spira Highlights Universal Basic Income's Success In Alleviating Poverty...

Thane: L&T To Redevelop 31.25 Lakh Sq Ft Land Parcel At Pachpakhadi

Thane: L&T To Redevelop 31.25 Lakh Sq Ft Land Parcel At Pachpakhadi